I was right about the circumstances of the trade before the announcements were made.
Im very impressed with how this company is run, the transparency, and how they have stuck diligently to the road map.
This is not your typical director announcement after they just dump on the open market to retail with the typical “Oh I’m selling because of “tax reasons””, Otto could have easily dumped and exercised at anytime and treated this like a lifestyle company.
He sold a parcel obviously after negotiation to an interested institutional party that wanted 5 million of them. It wasn’t a share dump to multiple retail buyers on market. Do you understand how business deals and rapport is brokered? Do you know Adrien Wing sold 1m shares on market in 2021 for around 90c then the price rocketed to $2?
If HC had their way, they’d never let a director sell ever! No excuses!
So let’s consider your idea…what if the director held their shares, told the interested institutional fund to “get bent”, creating reputational damage, then just sold on market to retail (the fund walked because they don’t play silly waiting games or they engage in more sinister tactics) after TGA approval and their first commercial deal, right when the company is actually getting started? you’d interpret that as a bad thing too most likely...that’d be disgustingly bad optics.
This product will be world changing. I’d put it up there with the NIPT harmony test…another ‘simple blood test’ (before it required invasive instruments into the womb) that can check for birth defects and gender with a blood test from the mother that is non invasive to the baby. It was released around 2014, made by a small private diagnostics company, bought by big pharma Roche and is now a 4.1B market size projected to grow to 13.16B by 2028. It’s now the thing every expecting mother has done. The colorectal cancer screening market alone is worth $18.6B now! Projected to $28B in 2028!
and we’re just starting with colostat, a non-invasive blood test that is the most accurate…with other blood test diagnostics in the pipeline. Imagine how many lives will be saved because it can pick up stage 1 bowel cancer better than anything
my mates mum died of stage 4 bowel cancer at 50. Had no idea she even had it until it was too late, wasn’t part of her general medical screening and didn’t think she’d be the one to have to shit in a bag (the current industry standard)
maybe you need to think more laterally and with a bit more business nous outside of “I would have kept my shares coz price will pump on tga approval announcement”. I’d actually say that is somewhat priced in.
The multiple commercial deals worldwide and gov contracts will be the key announcements.
RHY Price at posting:
$1.33 Sentiment: Buy Disclosure: Held
